Healthcare
Syntara (ASX:SNT) shareholders have experienced remarkable returns,...
March 19, 2025 09:33 AM AEDT | By Team Kalkine MediaHighlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareho...

Pro Medicus Limited (ASX:PME) have recently been purchasing more sha...
March 19, 2025 09:32 AM AEDT | By Team Kalkine MediaHighlights,Insiders hold 49% of ASX:PME shares, indicating significant vested interests.,Top 4 shareholders control 51% of the company, influencing ke...

Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval...
March 18, 2025 05:08 PM AEDT | By Team Kalkine MediaHighlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion effor...

CLEO Diagnostics initiates the transfer of intellectual property for...
March 18, 2025 03:31 PM AEDT | By Team Kalkine MediaHighlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibo...

Invex Therapeutics (ASX:IXC) - A Glimpse of Change
March 18, 2025 03:30 PM AEDT | By Team Kalkine MediaHighlights,Invex Therapeutics shares increased by 12% in a week,A significant decrease of 88% over three years,Total Shareholder Return (TSR) outperfo...

Would Next Science (NXS) Benefit from Reducing Its Debt?
March 18, 2025 03:30 PM AEDT | By Team Kalkine MediaHighlights:,Next Science reports a low net debt position with liquid assets nearly balancing liabilities.,The company’s revenue has grown, though oper...

Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to...
March 18, 2025 02:01 PM AEDT | By Team Kalkine MediaHighlights,Chimeric Therapeutics (CHM) announces a $3.2 million entitlement offer.,Funds to support ongoing clinical trials in neuroendocrine, colorec...

Major Developments in ASX Health and Biotech Firms
March 18, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights,Nanosonics receives FDA clearance for Coris, aimed at improving infection control in hospitals.,Imricor secures substantial funding for acc...

Medical Developments International (ASX:MVP) Sees Sharp Drop – What’...
March 17, 2025 06:56 PM AEDT | By Team Kalkine MediaHighlights,Medical Developments International (MVP) has declined by 27% in the last month.,The stock's price-to-sales ratio is significantly lower tha...

Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Y...
March 17, 2025 05:12 PM AEDT | By Team Kalkine MediaHighlights,Global Health (GLH) secures a $1 million contract with Youturn for digital health solutions.,The partnership aims to streamline operations...

Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial...
March 17, 2025 02:01 PM AEDT | By Team Kalkine MediaHighlights,Ansell Limited (ANN) has seen a 7.2% decline in stock value over the past month.,The company's return on equity (ROE) stands at 5.9%, below...

Ebos Group Dismisses Speculation on Real Pet Food Company Acquisitio...
March 17, 2025 12:55 PM AEDT | By Team Kalkine MediaHighlights,Ebos,Group (,ASX:EBO,) refutes reports of pursuing Real Pet Food Company.,Company,maintains,its focus on strategic, small-to-medium acquisi...

EMVision prepares for crucial stroke scanner trial this year
March 17, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,EMVision progresses from development to commercialization with portable brain scanners for stroke diagnosis.,A pivotal clinical trial supp...

US FDA Approvals: A Crucial Step for ASX Biotech Companies
March 17, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlight,FDA approval remains pivotal for global drug and device companies seeking market entry into the profitable US healthcare market.,ASX biotech...

Neurizon Therapeutics Advances Pharmacokinetic Studies to Address FD...
March 17, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlight,Neurizon submits a request to the FDA for clarification on pharmacokinetic studies to lift the clinical hold on NUZ-001.,The FDA is expected...

Race initiates its first Phase I trial location for a cardioprotecti...
March 16, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights,Race Oncology commences Phase I trials of RC220 in New South Wales, marking progress in its oncology treatment strategy.,The study evaluate...

Race receives ethical approval for Phase I trial in patients with so...
March 14, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,Ethics approval secured for a Phase I trial of RC220 bisantrene targeting solid tumors.,Patient enrollment set to begin at Southside Cance...

Oakridge International Insider Trust Pays Off as Stock Reaches AU$1....
March 13, 2025 05:31 PM AEDT | By Team Kalkine MediaHighlights,Recent share surge leads to significant gains for insiders.,Executive Chairman & CEO's substantial share purchase stands out.,Strong inside...

We're Eager to See How Mach7 Technologies Utilizes Its Cash Reserve...
March 13, 2025 05:30 PM AEDT | By Team Kalkine MediaHighlights:,Mach7 Technologies maintains a strong financial position with a substantial cash reserve and no debt.,Revenue growth has been steady, demo...

Early Detection of Diabetic Kidney Disease Gets a Boost with Promark...
March 13, 2025 02:14 PM AEDT | By Team Kalkine MediaHighlights,PromarkerD,launched in Australia for early diabetic kidney disease detection,Study shows,PromarkerD,outperforms standard tests in predictin...

Advertise your brand on Kalkine Media